New AI-powered robotic pool cleaner combines high-performance precision with intuitive design to advance the smart yard experience

BERLIN, Sept. 4, 2025 /PRNewswire/ — Aiper, the global leader in cordless robotic pool cleaners, is making waves again at IFA Berlin 2025 (September 5-9) with the debut of its first AI-powered robotic pool cleaner and most advanced product to date: the Scuba V3. The Scuba V3 is the world’s lightest vision-cognitive AI robotic pool cleaner with waterline retrieval, delivering a revolutionary leap in pool automation with advanced AI vision and an effortless user experience.

“Today’s consumers expect their smart home to extend beyond the indoors to the outdoors,” said Aiper CEO Richard Wang. “The Scuba V3 brings AI intelligence to the backyard, combining precision, convenience, and connectivity to deliver a truly effortless pool experience. As Aiper’s first AI robotic pool cleaner, it also marks a significant milestone in our journey to redefine smart outdoor living.”

The Scuba V3 will be available for purchase starting in early 2026 for $1,199, with key features including AI Vision Cleaning, which leverages a built-in camera and object recognition to detect and target over 20 different types of pool debris – from fine sand and dirt to sticks. With a significant boost in cleaning speed, the Scuba V3 ensures precise coverage through a combination of proactive vision and grid-pattern navigation. Backed by over two years of dedicated AI development and real-world testing across the U.S., Europe, and Australia, the Scuba V3’s vision system has been engineered to navigate with precision and intent. It intelligently avoids common underwater obstacles like drains, ladders, lights, steps, and even pool toys – ensuring uninterrupted, full-floor coverage every time.

The Scuba V3 also introduces AI Patrol Cleaning, a vision-guided scheduled cleaning mode that intelligently scans debris hotspots and targets only the zones that need attention which delivers up to 40% less runtime and energy usage while maintaining a 24/7 clean. This energy-efficient operation supports Aiper’s growing commitment to sustainability in pool tech.

Weighing just 16.5 pounds, about the same as a house cat, the Scuba V3 is designed for effortless use. With its quick-drain body and one-click activation, it’s incredibly easy to handle and operate, making it user-friendly for pool owners.

With its JetAssist™ motor and WaveLine™ technology, the Scuba V3 also achieves uninterrupted horizontal waterline cleaning while the MicroMesh™ ultra-filtration system ensures the finest debris is trapped thus achieving a crystal-clear pool every time. Designed for today’s connected homes, the Scuba V3 supports wireless charging via a dock and includes smart diagnostics, auto-calibration, and over-the-air (OTA) software updates via Aiper’s free mobile app.

The new Scuba V3 will make its debut at the Aiper booth (Hall 9-111) at Messe Berlin during IFA. A special launch event for the new product will also take place at the Aiper booth on September 5 from 11:00 AM to 12:00 PM CEST. 

IFA attendees can also learn about Aiper’s latest innovations at ShowStoppers @ IFA on September 4 at the South Entrance Hall, where the brand will also showcase award-winning products and advanced models such as the IrriSense and Scuba X1 Pro Max.

For more information about Aiper visit Aiper.com and follow Aiper on LinkedIn, Facebook, Instagram, TikTok, and X.

About Aiper

Aiper is the global pioneer of cordless robotic pool cleaning technology and a leader in smart yard product solutions. Through its “Bring Vacation Home” campaign, Aiper empowers homeowners to transform their backyards into a personal vacation retreat with the help of innovative, smarter, and greener product solutions that effortlessly handle pool and lawn maintenance to save time, money, and energy. From state-of-the-art pool cleaners to intelligent irrigation systems, Aiper delivers a comprehensive backyard ecosystem of products that simplify outdoor maintenance so users can enjoy more leisure and fun. Renowned for excellence, Aiper products have garnered prestigious awards, including the Red Dot Design Award, the iF Design Award, and editorial awards from USA Today and TWICE. Additionally, Aiper has been recognized as a CES Innovation Awards honoree in 2023, 2024, and 2025, underscoring its commitment to pioneering smart yard solutions.

SHANGHAI, Sept. 4, 2025 /PRNewswire/ — Angel Yeast (SH600298), a leading global provider of yeast and fermentation-based ingredients, announced today that its proprietary yeast protein, AngeoPro, has been granted Generally Recognized as Safe (GRAS) status by the U.S. Food and Drug Administration (FDA). 

The designation not only affirms the safety of the product but also marks a significant milestone in Angel Yeast’s effort to expand the role of sustainable yeast protein in the global food supply. Positioned as a solution to challenges such as food security, climate change, and the rising need for protein, AngeoPro provides food companies and consumers with an ingredient that is safe, effective, and environmentally responsible. 

AngeoPro is a high-quality fermented yeast protein that can replace traditional protein sources—including soy, whey, and animal-based proteins—across a wide range of food categories. It is nutritionally complete, providing all essential amino acids, vitamins, and minerals. With a low carbon footprint and high resource efficiency, AngeoPro offers a scalable, sustainable approach to meeting growing worldwide protein demand.

Thanks to its versatility and clean-label profile, AngeoPro is well suited for use in plant-based products, sports nutrition, and alternative meat applications, particularly in the United States and Europe where consumers increasingly weigh health and environmental impact when choosing foods.

As the food industry accelerates its shift toward sustainable and efficient production, fermented protein is emerging as a cornerstone of future food systems. According to 2024 State of the Industry Report: Fermentation, released in May 2025 by The Good Food Institute (GFI), fermented protein is reshaping the global food landscape faster than anticipated, driven by its scalability, low carbon emissions, and strong functionality. Despite a sluggish private market, the category attracted $651 million in private capital and $510 million in public funding in 2024, demonstrating strong investor confidence and its potential to deliver on sustainability goals.

“The GRAS certification not only validates the safety and quality of AngeoPro but also represents a meaningful step forward in Angel Yeast’s mission to provide innovative and sustainable solutions to the global food industry,” said Hang Tao, General Manager of Angel Yeast North America. “We are dedicated to using our expertise in yeast fermentation to redefine protein sources and help food producers develop healthier, more sustainable products for consumers.”

Aurzen ZIP Cyber Edition — The Future in Your Pocket, The Moment to Share.

BERLIN, Sept. 4, 2025 /PRNewswire/ — Aurzen today announced the global unveiling of its flagship ZIP Cyber Edition projector at IFA 2025, marking the first worldwide showcase of this special edition. As the centerpiece of Aurzen’s exhibition, the ZIP Cyber Edition reflects the company’s design philosophy and introduces futuristic aesthetics to its pocket-sized projector line.

The ZIP Cyber Edition is inspired by sleek urban architecture, the precision of high-performance sports cars, and cyberpunk visuals from movies and video games. Its design incorporates subtle circuit-inspired details and layered structures, conveying high-tech craftsmanship. Compact and battery-powered, it enables immersive entertainment anywhere. Palm-sized yet powerful, it transforms any space into a shared experience — from movie nights to on-the-go gaming and gatherings. Every detail, from intuitive controls to built-in audio, is designed for effortless use, allowing users to focus on the moments that matter.

An Ecosystem for a Cyber Lifestyle

The ZIP Cyber Edition is enhanced by a family of modular accessories, enabling users to customize their portable setup:

• Seamless Streaming: The CastPlay-C Dongle delivers plug-and-play, DRM-protected streaming from platforms like Netflix and mirrors a Nintendo Switch with <80ms latency for smooth gaming.
• Extended Power: The PowerPlay Magnetic Charging Stand doubles as a desktop dock and 10,000mAh power bank, extending entertainment for marathons or long sessions.
• Project Anywhere: The MagPlay Dual-Sided Mount uses a vacuum grip and magnetic lock to attach the ZIP to unconventional surfaces such as windows, whiteboards, or tiles.
• The Perfect Picture: The ScreenPlay is an ultra-portable 20-inch A3-sized screen that sets up in seconds, providing a perfect canvas for content anywhere.
• Effortless Connectivity: The CastPlay Wireless HDMI Dongle supports peer-to-peer mirroring from laptops and other devices without Wi-Fi.

Key Features of the Aurzen ZIP Cyber Edition

• Tri-Fold Portability: Ultra-compact design weighing only 280g.
• Crisp Visuals: 720p HD resolution with 100 ANSI lumens brightness.
• Instant Setup: Zero-lag ToF autofocus and vertical keystone correction.
• Built-in Power: A 5000mAh battery delivers up to 1.5 hours of entertainment on the go.

Pricing & Availability

The Aurzen ZIP Cyber Edition will be available for pre-order on September 5, 2025, with a retail price of USD 429.99. Pre-orders will begin exclusively on Aurzen’s official website.

The Aurzen ZIP Cyber Edition and its full ecosystem will be available for hands-on demonstrations at IFA 2025, Messe Berlin, Hall H21, Booth H21-111, from September 5–9.

About Aurzen

Aurzen is a global innovator in smart projection technology, dedicated to creating high-value, user-friendly entertainment solutions for modern lifestyles. Combining cutting-edge optical engineering with intuitive software and user-centric design, Aurzen delivers products that bring big-screen experiences to any space. The company pioneered the world’s first Tri-Fold Truly Portable projector, ZIP, and its designs have been recognized with multiple international awards, including iF Design Award, Red Dot Award, G-Mark Award and IDEA Award.

For more information, visit www.aurzen.com.

Contact: media@aurzen.com

The LuMon™ System is also CE-marked under EU MDR and registered with TGA in Australia.

LINCOLN, R.I., Sept. 4, 2025 /PRNewswire/ — Sentec, a global leader in non-invasive patient monitoring, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LuMon™ Electrical Impedance Tomography (EIT) system for premature infant, infant, adolescent, and adult patients—making it the first EIT technology in the United States available for premature infants and for spontaneously breathing patients. 

The LuMon™ EIT System delivers functional lung imaging directly at the NICU bedside—without radiation—helping clinicians better tailor therapy to each patient’s unique needs.

The LuMon™ EIT System delivers functional lung imaging directly at the bedside—without radiation—helping clinicians better tailor therapy to each patient’s unique needs.

Clearance for Premature Infant Use Supports NICU Clinicians to Personalize Ventilatory Care

While the LuMon™ System can be used to monitor a variety of patients, whether ventilated or spontaneously breathing, the premature infants and other patients in the NICU may stand to benefit the most from EIT’s insights at the bedside.

“Neonatal patients present enormous complexity, especially for ventilation; there’s very little room for error, particularly in our smallest patients – and the consequences can follow these babies all their lives,” said Dr. David Tingay, Clinical Neonatologist and Respiratory Physiotherapist at Royal Children’s Hospital in Melbourne, Australia.

Dr. Tingay has done extensive research with the LuMon ™ EIT system in infant patients continued, “Without EIT, there’s been no way for us to continuously see what is happening inside the lungs at the bedside to understand the impact of our interventions better as we perform them.”

The ability to safely visualize lung function at the bedside, continuously and in real time, has enormous potential for guiding neonatal care and, according to Dr. Tingay, “EIT provides immediate imaging of regional lung function at the bedside. That visualization helps us better understand each patient’s respiratory condition and determine the strategies we need to employ for their specific needs.”

With the first-ever FDA clearance for premature infants and soft, fabric belts small enough for even very low birthweight infants, the LuMon™ System is positioned to help clinicians deliver gentle and effective respiratory care for the uniquely fragile and complex patients in the NICU.

While the basis of electrical impedance tomography and its use for imaging regional lung function has been present in research for many years, the LuMon™ system is first EIT technology available for routine clinical bedside use with premature infants in the United States, and can impact patient care and clinical decision making today.

Learn more about Electrical Impedance Tomography from Sentec

About Electrical Impedance Tomography

Electrical impedance tomography works by sending gentle, alternating currents through the thorax via a comfortable, skin-friendly fabric belt and measuring the resulting voltages to produce dynamic images of regional impedance variations due to breathing. This enables clinicians to evaluate real-time responses to regional ventilation changes such as those resulting from positioning, ventilator settings, and pharmaceuticals, facilitating more precise and individualized care decisions.

About the LuMon™ System

Designed for critical care environments, including neonatal, pediatric, and adult intensive care units, the LuMon™ System enables bedside monitoring of regional impedance variations in the thorax to support assessment of a patient’s respiratory status. This information assists in the real-time evaluation of air distribution and lung recruitment, supporting timely interventions that may help improve patient outcomes.

About Sentec

Sentec is a Swiss-American medical device company specializing in respiratory care. Since its founding in 1999, Sentec utilizes a deep-tech approach that is founded on advanced science and avant-garde technologies for respiratory patients across care areas. Sentec provides healthcare professionals worldwide with non-invasive, continuous monitoring and effective therapeutic solutions.

Photo – https://laotiantimes.com/wp-content/uploads/2025/09/sentec_lumon_eit_system_in_nicu.jpg

Logo – https://laotiantimes.com/wp-content/uploads/2025/09/sentec_logo.jpg

KITCHENER, ON, Sept. 4, 2025 /PRNewswire/ — Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) today announced that e-STORAGE, which is part of the Company’s majority-owned subsidiary CSI Solar Co., Ltd. (“CSI Solar”), will launch its next generation modular battery, FlexBank 1.0, at RE+ in Las Vegas next week. The new system is expected to be ready for deployment in 2026.

Expanding e-STORAGE’s BESS solution portfolio, FlexBank 1.0 is a scalable energy storage platform designed to meet the needs of diverse utility-scale applications. It delivers up to 8.36 MWh energy capacity. The new modular open-frame architecture enables each cabinet to function as an independent building block, greatly simplifying logistics and installation. The FlexBank platform also serves as a foundation for e-STORAGE’s next-generation battery cell technologies that will feature higher amperage in a larger form factor and superior performance characteristics.

Built on e-STORAGE’s proven 314Ah Lithium Iron Phosphate (LFP) cell technology, FlexBank 1.0 enhances safety through a multi-tiered protection system. Within each cabinet, cells are protected by heat barriers, a three-level electrical protection system, and advanced cell-level precision management. The modular design is engineered to prevent thermal propagation between cabinets, substantially mitigating fire risk.

In addition, FlexBank 1.0’s skid-mounted design enables rapid on-site assembly and versatile layout configurations, including side-by-side and back-to-back installations. This flexibility reduces EPC costs while maximizing project energy density. The system is fully compatible with power conversion systems, ensuring seamless integration for both new deployments and site augmentations.

Colin Parkin, President of e-STORAGE, stated, “FlexBank 1.0 is the strategic evolution of our utility-scale energy storage platform, engineered to address our customers’ critical needs for safe, adaptable, and cost-effective solutions. By dramatically simplifying deployment, we are providing a more reliable and adaptable technology that will accelerate the global transition to renewable energy and deliver tangible value for developers and investors.”

FlexBank 1.0 will be unveiled at RE+ 2025 in Las Vegas, Nevada, from September 9 to September 11, 2025. Visit Canadian Solar’s booth V10031 to learn more.

About Canadian Solar Inc.

Canadian Solar is one of the world’s largest solar technology and renewable energy companies. Founded in 2001 and headquartered in Kitchener, Ontario, the Company is a leading manufacturer of solar photovoltaic modules; provider of solar energy and battery energy storage solutions; and developer, owner, and operator of utility-scale solar power and battery energy storage projects. Over the past 24 years, Canadian Solar has successfully delivered nearly 165 GW of premium-quality, solar photovoltaic modules to customers across the world. Through its subsidiary e-STORAGE, Canadian Solar has shipped over 13 GWh of battery energy storage solutions to global markets as of June 30, 2025, boasting a $3 billion contracted backlog as of June 30, 2025. Since entering the project development business in 2010, Canadian Solar has developed, built, and connected approximately 12 GWp of solar power projects and 6 GWh of battery energy storage projects globally. Its geographically diversified project development pipeline includes 27 GWp of solar and 80 GWh of battery energy storage capacity in various stages of development. Canadian Solar is one of the most bankable companies in the solar and renewable energy industry, having been publicly listed on the NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.

About e-STORAGE

e-STORAGE is a subsidiary of Canadian Solar and a leading company specializing in designing, manufacturing, and integrating battery energy storage systems for utility-scale applications. e-STORAGE offers proprietary battery energy storage solutions, comprehensive EPC services, and innovative solutions aimed at improving grid operations. Currently, e-STORAGE operates fully automated, state-of-the-art manufacturing facilities with an annual battery energy storage system capacity of 10 GWh and battery cell capacity of 3 GWh. For more info, please refer to the Media&PR section of www.csestorage.com and follow our LinkedIn page.

Safe Harbor/Forward-Looking Statements 

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the “Safe Harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as “believes,” “expects,” “anticipates,” “intends,” “estimates,” the negative of these terms, or other comparable terminology. Factors that could cause actual results to differ include general business, regulatory and economic conditions and the state of the solar power and battery energy storage market and industry; geopolitical tensions and conflicts, including impasses, sanctions and export controls; volatility, uncertainty, delays and disruptions related to global pandemics; supply chain disruptions; governmental support for the deployment of solar power and battery energy storage; future available supplies of silicon, solar wafers and lithium cells; demand for end-use products by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as China, the U.S., Europe, Brazil and Japan; changes in effective tax rates; changes in customer order patterns; changes in product mix; changes in corporate responsibility, especially environmental, social and governance (“ESG”) requirements; capacity utilization; level of competition; pricing pressure and declines in or failure to timely adjust average selling prices; delays in new product introduction; delays in utility-scale project approval process; delays in utility-scale project construction; delays in the completion of project sales; the pipeline of projects and timelines related to them; the ability of the parties to optimize value of that pipeline; continued success in technological innovations and delivery of products with the features that customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange and inflation rate fluctuations; litigation and other risks as described in the Company’s filings with the Securities and Exchange Commission, including its annual report on Form 20-F filed on April 30, 2025. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.

CANADIAN SOLAR INC. INVESTOR RELATIONS CONTACT
Wina Huang
Investor Relations
Canadian Solar Inc.
investor@canadiansolar.com

e-STORAGE MEDIA CONTACT
marketing@csisolar.com 

Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT

LOS ANGELES, Sept. 4, 2025 /PRNewswire/ — 4DMedical, a leader in advanced respiratory imaging, today announces U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ™, the world’s first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the U.S. Centers for Medicare & Medicaid Services (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.

4DMedical CT:VQ™ turns a routine chest CT into ventilation–perfusion imaging—no contrast required.

CT:VQ converts standard, non–contrast chest CTs into quantitative, lobar ventilation (V) and perfusion (Q) maps. Delivered as software–as–a–service, it integrates directly with routine radiology workflows (DICOM-based, PACS reporting) and leverages the U.S. installed base of approximately 14,500 CT scanners, bringing functional lung imaging to sites without nuclear medicine capacity.

“CT:VQ gives clinicians all the contrast—and none of the injections,” said Andreas Fouras, PhD, founder and CEO of 4DMedical. “With FDA clearance and Medicare payment in place, any hospital with a CT scanner can turn a routine chest CT into a high–resolution ventilation–perfusion study in minutes, without new hardware or workflow complexity. The word ‘breakthrough’ is overused, but we believe the unprecedented capabilities of CT:VQ qualify for that description.”

CT:VQ transforms a routine non-contrast chest CT into a reimbursable V/Q study, eliminating the need for new hardware. Patients skip injections and complete the entire process in a single CT appointment. Radiologists then receive high-resolution, quantitative V/Q maps directly in PACS. This allows pulmonologists to gain actionable information for PE workups, CTEPH assessment, COPD phenotyping, BLVR planning, and ongoing monitoring. Since CT:VQ operates on existing scanners, hospitals and imaging centers, including those without nuclear medicine, the technology can be implemented to immediately expand access to community and rural patients.

More than one million nuclear V/Q scans are performed annually in the U.S. 4DMedical’s clinical validation for CT:VQ included quantitative performance testing against SPECT, expert reader studies, and real–world cases across multiple lung conditions. Early U.S. clinical partners have included Stanford University and Brooke Army Medical Center, with the later presenting initial findings at the recent 2025 American Thoracic Society meeting.

About 4DMedical
4DMedical Limited (ASX:4DX) is a global medical technology company transforming respiratory care through advanced imaging and artificial intelligence. Its patented XV Technology® powers the FDA-cleared XV LVAS®, CT LVAS™, and CT:VQ™, which deliver quantitative ventilation and perfusion analysis from non-contrast chest CT scans.

Delivered as secure, cloud-based Software-as-a-Service, 4DMedical’s solutions integrate seamlessly with existing hospital systems, improving physician productivity and enabling more personalized care.

Following its 2023 acquisition of Imbio, 4DMedical delivers the most comprehensive cardiopulmonary analysis portfolio, spanning ventilation, perfusion, and parenchymal assessment on a single, cloud-delivered platform.

Learn more at www.4dmedical.com

Photo – https://laotiantimes.com/wp-content/uploads/2025/09/4dmedical_ct_vq_non_contrast_lung_ventilation_perfusion.jpg
Logo – https://laotiantimes.com/wp-content/uploads/2025/09/4dmedical_logo.jpg

MILAN, Sept. 4, 2025 /PRNewswire/ — Enfinity Global Inc., a leading renewable energy company, today announced the successful financial close of €316 million for the construction of eight utility-scale solar power plants in Italy. With a combined capacity of 276 MW, the projects are strategically located across the regions of Emilia Romagna, Basilicata, and Lazio. The solar power plants are expected to be fully operational by the end of 2026.

The financing was arranged through a club deal structure, with ING, Rabobank, and BNP Paribas, acting as Mandated Lead Arrangers, Lenders, Original Hedging Counterparties and Green Loan Coordinators. The funding package includes €214 million in non-recourse senior debt alongside €101 million in facilities for VAT, letters of credit (LCs) for PPAs, PV modules and decommissioning obligations.

The energy generated by this new portfolio is expected to total approximately 403 GWh annually, resulting in an estimated reduction of 109,000 tons of CO₂e emissions each year. This is equivalent to the annual electricity consumption of around 150,000 Italian households.

“We are proud to partner with Rabobank, BNP Paribas, and ING to continue accelerating the energy transition in Italy,” said Carlos Domenech, CEO of Enfinity Global. “This milestone further validates our long-term vision and commitment to building a sustainable energy platform that enables our customers to access cost-competitive energy to propel their growth, while we drive investment to Italy and create new jobs.”

“This is our largest project financing to date in Italy, reinforcing our leadership in the market and expanding our presence in regions with high energy demand,” commented Julio Fournier Fisas, Enfinity Global General Manager for Europe. “This deal supports our strategy of bringing energy production closer to consumption centers, allowing us to better serve the growing energy needs of corporate and industrial clients based on their geographic location.”

This financing brings Enfinity Global’s total raised in Italy in the last two years to €1.3 billion, as the company advances its 8 GW pipeline of solar PV and storage projects in the country, including 564 MW currently under construction in Lazio and Emilia-Romagna. Enfinity currently leads Italy’s solar PPA market, having signed 805 MW of long-term agreements with industrial, corporate, and utility off-takers.

“BNPP Energy and Infrastructure is proud to close our first project finance transaction with Enfinity, marking the beginning of a strong partnership in the renewable energy sector. This landmark financing supports the deployment of a large-scale solar portfolio in Italy, reinforcing our commitment to accelerating energy transition in one of Europe’s most dynamic markets, further expanding our role as a leading player in the sector. We look forward to collaborating again with Enfinity to support their significant growth strategy worldwide,” commented Thomas Beaumont, Head of Energy Origination EMEA at BNP Paribas.

“ING is proud to again have been selected by Enfinity Global to assist in this important financing in Italy. This is ING’s third repeat mandate in Italy with Enfinity Global, demonstrating our shared ambition to grow renewable energy and excellent local capabilities in the market. ING remains committed to growing our renewables lending commitment globally to €7.5 billion annually by 2025 and we look forward to continuing the journey with Enfinity Global in renewables in Italy and elsewhere,” commented Diederik van den Berg, Managing Director, Global Lead Renewables & Power.

“Rabobank Project Finance congratulates Enfinity Global and our co-lenders BNP Paribas and ING on another successful financial close for the financing of a portfolio of solar PV assets in Italy. Following the successful close of the two financings last year, this is our third Italian portfolio financing with Enfinity Global. Rabobank is excited to work with such an experienced and large renewable energy player acting globally, and has enjoyed pleasant, efficient, and professional cooperation. This project further strengthens Rabobank’s ambition to be a leading player in the renewable energy sector globally and increases our footprint in Italy. We look forward to supporting Enfinity Global’s growth strategy as they continue to build out their portfolio of renewable energy assets,” said Marc Schmitz, Head of Project Finance Europe and Asia at Rabobank.

The deal was supported by a team of advisors, including Bondholders as Facility Agent and Documentary and Security agent, Gianni & Origoni as lenders’ legal advisor, Bird & Bird as borrower’s legal advisor, Astris Finance as financial advisor, Vector Renewables as technical advisor, PricewaterhouseCoopers as auditor advisor, and MAG Consulting Srl as insurance advisor.